T1	Participants 48 100	patients with type 2 diabetes in the PROactive Study
T2	Participants 211 240	Patients with type 2 diabetes
T3	Participants 570 610	high-risk patients with type 2 diabetes.
T4	Participants 672 748	5238 patients with type 2 diabetes who had evidence of macrovascular disease
T5	Participants 763 813	patients from primary-care practices and hospitals
T6	Participants 2424 2484	type 2 diabetes who have a high risk of macrovascular events
